Cart
sales@molnova.com
Pterine-6-carboxylic acid
CAS No. 948-60-7
Pterine-6-carboxylic acid( —— )
Catalog No. M37805 CAS No. 948-60-7
Pterine-6-carboxylic acid (6-Carboxypterin) is a photodegradation product of folic acid, which can be used as a photosensitive agent to study the molecular mechanism of UVA breaking DNA structure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 66 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePterine-6-carboxylic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPterine-6-carboxylic acid (6-Carboxypterin) is a photodegradation product of folic acid, which can be used as a photosensitive agent to study the molecular mechanism of UVA breaking DNA structure.
-
DescriptionPterin-6-carboxylic acid serves as a precursor for the formation of folate, which plays a critical role in cell growth, development, and repair. Pterine-6-carboxylic acid has been studied for its potential as a fluorescent dye.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE | DNA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number948-60-7
-
Formula Weight207.15
-
Molecular FormulaC7H5N5O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1nc2ncc(nc2c(=O)[nH]1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Oluwasegun Modupe, et al. A spectrophotometric method for determining the amount of folic acid in fortified salt. J Agric Food Res. 2020 Dec:2:100060.
molnova catalog
related products
-
TAK-063
TAK-063 (Balipodect) is a highly potent, selective, orally active PDE10A inhibitor with IC50 of 0.3 nM.
-
ONO-8430506
ONO-8430506 is an orally available, potent autotaxin (ATX)/ENPP2 inhibitor (IC90: 100 nM) that inhibits ATX activity in mouse plasma.
-
Verofylline
Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.
